Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 113 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1121 10.5 months Non-Sqaumous NSCLC 5 Biologic therapy
Chemotherapy
David Geffen School of Medicine at UCLA United States 8/2014
Treatment Details: Patients: This phase 3 study involved non-small cell lung cancer patients who had received prior platinum-based chemotherapy and were divided into two separate treatment groups. Group A co
 
1122 10.5 months Malignant pleural mesothelioma 4 Chemotherapy
Istituto Clinico Humanitas Italy 4/2011
Treatment Details: Patients: This study involved 31 malignant pleural mesothelioma patients who had received prior treatment. The median age of the group was 65 years and 68% were male. Treatment: Patien
 
1123 10.5 months Metastatic melanoma 4 Biologic therapy
Chemotherapy
Abramson Cancer Center at the University of Pennsylvania United States 12/2009
Treatment Details: Patients: This phase 2 study involved 167 patients with metastatic melanoma. The median age was 61, ranging from 26 to 84 years of age. Most (69%) of the patients were men. Treatment
 
1124 10.5 months Metastatic collecting duct carcinoma 4 Chemotherapy
Georges Pompidou European Hospital France 5/2007
Treatment Details: Patients: This phase II study involved 23 patients with metastatic collecting duct carcinoma. The median age was 65 years, ranging from 18-74. Fifty-seven percent of the patients were wo
 
1125 10.5 months Malignant Mesothelioma 3 Biologic therapy
Chemotherapy
The Royal Marsden Hospital United Kingdom 2/2002
Treatment Details: Patients: This Phase I study involved 13 patients with malignant mesothelioma. Treatment: The treatment consisted of a suspension of heat-killed Mycobacterium vaccae (SRL172), a fast gr
 
1126 10.5 months Advanced NSCLC 3 Chemotherapy
Radiation
Tulane University Health Sciences Center United States 2/2003
Treatment Details: Patients: This study involved 19 patients with advanced (stages IIIA or IIIB) non-small cell lung cancer. The median age of patients was 60 years old. Treatment: The treatment consisted
 
1127 10.5 months Recurrent GBM 4 Chemotherapy
Radiation
University of Texas M.D. Anderson Cancer Center United States 3/2002
Treatment Details: Patients: This Phase II study involved 44 patients with recurrent glioblastoma multiforme. Treatment: The treatment consisted of temozolomide (temodar) and the matrix metalloproteinase in
 
1128 10.5 months Advanced NSCLC 3 Chemotherapy
Memorial Sloan-Kettering Cancer Center United States 9/2005
Treatment Details: Patients: This Phase III study involved 1059 patients with advanced (stage IIIB/IV) non-small-cell lung cancer. None of the patients had been treated. The patients were randomly assigned i
 
1129 10.5 months Advanced NSCLC 4 Chemotherapy
Oncology Institute of Bari Italy 10/2002
Treatment Details: Patients: This Phase II study involved 47 patients with advanced (stage IIIB or IV) non-small-cell lung cancer. Treatment: Treatment consisted of two drugs gemcitabine (gemzar) and doce
 
1130 10.5 months Small cell carcinoma of the prostate 5 Chemotherapy
The University of Texas M.D. Anderson Cancer Center United States 7/2002
Treatment Details: Patients: This Phase II study involved 38 patients with small-cell carcinoma of the prostate. The median age was 65 years Treatment: The treatment consisted of three chemotherapy drugs
 
Page 113 of 187  | Previous Page  | Next Page